Columbia Wanger Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $42.3M | Sell |
495,734
-41,141
| -8% | -$3.51M | 0.63% | 59 |
|
|
2017
Q3 | $45.6M | Buy |
536,875
+70,343
| +15% | +$5.97M | 0.67% | 54 |
|
|
2017
Q2 | $35.3M | Buy |
466,532
+315,159
| +208% | +$23.9M | 0.5% | 95 |
|
|
2017
Q1 | $10M | Buy |
151,373
+9,352
| +7% | +$618K | 0.14% | 176 |
|
|
2016
Q4 | $9M | Sell |
142,021
-56,100
| -28% | -$3.56M | 0.13% | 178 |
|
|
2016
Q3 | $12.6M | Sell |
198,121
-126,232
| -39% | -$8.04M | 0.17% | 170 |
|
|
2016
Q2 | $24.1M | Buy |
324,353
+71,024
| +28% | +$5.28M | 0.28% | 138 |
|
|
2016
Q1 | $16.9M | Buy |
+253,329
| New | +$16.9M | 0.18% | 147 |
|